| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005685 Starch derivative mixtures |
| 01/03/2013 | US20130005643 Method for preparing nano-particles |
| 01/03/2013 | US20130004604 Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals |
| 01/03/2013 | US20130004602 Lotion composition and fibrous structure comprising same |
| 01/03/2013 | US20130004592 Pharmaceutical compositions for parenteral administration |
| 01/03/2013 | US20130004557 Antimicrobial Resin Compositions |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004452 Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof |
| 01/03/2013 | US20130004441 Non-aqueous structured compositions |
| 01/03/2013 | US20130004434 Gastroretentive, Extended Release Composition Of Therapeutic Agent |
| 01/03/2013 | CA2840734A1 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | CA2840571A1 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | CA2840491A1 Topical ophthalmological pharmaceutical composition containing sorafenib |
| 01/03/2013 | CA2840329A1 Topical ophthalmological pharmaceutical composition containing regorafenib |
| 01/03/2013 | CA2839624A1 Applicator system for applying a viscous liquid to the human skin |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839619A1 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839410A1 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diabetes containing the same as active ingredient |
| 01/03/2013 | CA2839387A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 01/03/2013 | CA2839179A1 A new stable anesthetic composition for reducing skin reactions |
| 01/03/2013 | CA2838976A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | CA2836914A1 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents |
| 01/02/2013 | EP2540764A2 Poly(organophosphazene) composition for biomaterials |
| 01/02/2013 | EP2540320A1 Leptomycin derivatives |
| 01/02/2013 | EP2540319A1 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 01/02/2013 | EP2540311A1 Composite body for antigen or drug delivery |
| 01/02/2013 | EP2540298A1 Coated solid preparation |
| 01/02/2013 | EP2540294A1 Sustained-release solid preparation for oral use |
| 01/02/2013 | EP2540292A1 DHA and EPA in the reduction of oxidative stress |
| 01/02/2013 | EP2540286A1 Hard capsule and method for producing same |
| 01/02/2013 | EP2540284A2 Compositions and methods for stabilized polysaccaride formulations |
| 01/02/2013 | EP2540283A1 Improved botulinum toxin compositions |
| 01/02/2013 | EP2539451A1 Compositions for targeted delivery of sirna |
| 01/02/2013 | EP2538981A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2013 | EP2538980A1 Cross-linking agents for hydrogels that contain cleavable peptides and short-chain polymers |
| 01/02/2013 | EP2538979A1 Adhesive complex coacervates produced from electrostatically associated block copolymers and methods for making and using the same |
| 01/02/2013 | EP2538977A1 Dna dendrimers as thermal ablation devices |
| 01/02/2013 | EP2538976A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 01/02/2013 | EP2538974A1 Protein formulations |
| 01/02/2013 | EP2538957A2 Car peptide for homing, diagnosis,&targeted therapy for pulmonary and fibrotic disorders |
| 01/02/2013 | EP2538955A2 Pharmaceutical or neutraceutical formulation |
| 01/02/2013 | EP2538938A1 Fungal nail treatment composition |
| 01/02/2013 | EP2538929A2 Sustained delivery of therapeutic agents to an eye compartment |
| 01/02/2013 | EP2538923A2 Taste-masked powder for suspension compositions of methylprednisolone |
| 01/02/2013 | EP2538921A2 Method and apparatus for preparing novel liposome |
| 01/02/2013 | EP2538802A1 Method for preparing a composition including a compound containing vanillin and ethylvanillin, composition thus obtained and use thereof |
| 01/02/2013 | EP2538779A1 Diversion-and/or abuse-resistant compositions and methods for making the same |
| 01/02/2013 | CN202637503U Hollow capsule |
| 01/02/2013 | CN1951500B Colouring application of pearly pigment in medicine |
| 01/02/2013 | CN1919846B Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 01/02/2013 | CN1777411B Transmucosal drug delivery system |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858851A Carbosilane dendrimers and the use thereof as antiviral agents |
| 01/02/2013 | CN102858794A Peptides whose uptake in cells is controllable |
| 01/02/2013 | CN102858374A Thermogelling anaesthetic compositions |
| 01/02/2013 | CN102858373A Easily dosable solid preparation |
| 01/02/2013 | CN102858372A Skin irritation suppressant and transdermal preparation |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102858366A Solution Preparation Containing Stabilized Antibody |
| 01/02/2013 | CN102858348A Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 01/02/2013 | CN102858337A Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 01/02/2013 | CN102858333A Treatment of respiratory disorders |
| 01/02/2013 | CN102858332A Ketoprofen-containing aqueous adhesive skin patch |
| 01/02/2013 | CN102858321A Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives |
| 01/02/2013 | CN102858312A Aqueous composition contained in container |
| 01/02/2013 | CN102858150A Water-soluble iron supply agent with reducing power and with coffee grounds or tea dregs as raw material |
| 01/02/2013 | CN102851291A Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 01/02/2013 | CN102850710A Framework material for medical plaster and preparation method thereof |
| 01/02/2013 | CN102850532A Thermo-sensitive self-assembled tri-block copolymer, pharmaceutical composition, and preparation method and application of pharmaceutical composition |
| 01/02/2013 | CN102850469A O-carboxymethyl chitosan-stearic acid polymer as well as synthesis method thereof and application of polymer |
| 01/02/2013 | CN102850443A Integrin blocker polypeptides and application thereof |
| 01/02/2013 | CN102847171A Gene medicine for treating liver cancer and preparation method and application thereof |
| 01/02/2013 | CN102847170A Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 01/02/2013 | CN102847166A Prodrug of oridonin with polyethylene glycol serving as vector and preparation method thereof |
| 01/02/2013 | CN102847165A Matrix for navel-applied plaster and preparation method thereof |
| 01/02/2013 | CN102847164A Application of chrysalis oil in improving small molecule drug bioavailability |
| 01/02/2013 | CN102847163A Film coating agent for hygroscopic solid traditional Chinese medicine preparation and preparation method thereof |
| 01/02/2013 | CN102847162A Method for preparation of active immunoadsorbent carrier |
| 01/02/2013 | CN102847161A Application of tetrahydropyrimidine and its derivate in preparation of pulmonary absorption enhancer medicine |
| 01/02/2013 | CN102847142A Oral biological medicine used for treating chemotherapy and radiotherapy syndromes, and preparation method thereof |
| 01/02/2013 | CN102847138A Medicine composition containing muscular amino acid and nucleoside compound and preparation method thereof |
| 01/02/2013 | CN102847136A Composition for enzyme inhibition |
| 01/02/2013 | CN102847102A Preparation method of zingiber corallinum hance essential oil/hydroxypropyl-beta-cyclodextrin clathrate and preparation method of zingiber corallinum hance essential oil/hydroxypropyl-beta-cyclodextrin clathrate injection |
| 01/02/2013 | CN102846723A Tuber fleeceflower root zinc lactate compound tablets and preparation method thereof |
| 01/02/2013 | CN102846671A Preparation method of traditional Chinese medicine preparation |
| 01/02/2013 | CN102846656A Skin mucosa disinfecting liquid and preparation method thereof |
| 01/02/2013 | CN102846653A Compositions and methods for stabilized polysaccharide formulations |
| 01/02/2013 | CN102846650A Florfenicol compound composition and preparation method thereof |
| 01/02/2013 | CN102846649A Doxycycline hydrochloride for livestock compound injection and preparation method thereof |
| 01/02/2013 | CN102846613A Formulations for parenteral delivery of compounds and uses thereof |
| 01/02/2013 | CN102846599A External-use composite |
| 01/02/2013 | CN102846589A Long term weight maintenance |
| 01/02/2013 | CN102846586A L-Se-methylselenocysteine inclusion compound and preparation method thereof |
| 01/02/2013 | CN102846585A Formulations of low dose diclofenac and beta-cyclodextrin |
| 01/02/2013 | CN102846581A Ambroxol hydrochloride oral fast-dissolving film and preparation method thereof |
| 01/02/2013 | CN102846580A Application of rifampicin capsule in preparation of pharmaceutical for treating hemorrhoids |
| 01/02/2013 | CN102846579A Valsartan medicinal capsule and preparation method thereof |
| 01/02/2013 | CN102846578A Fenbendazole effervescence particle for livestock and poultry and preparation method thereof |